Research graph
References from Development and validation of DSTOX: an integrated QSAR platform adhering to ICH M7 guidelines for mutagenicity assessment of drug impurities. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2023 · External reference
US FDA Experience in the Regulatory Application of (Q)SAR
2020 · External reference
Unresolved reference
2016 · External reference
Unresolved reference
2020 · External reference
An Open Source Multistep Model to Predict Mutagenicity from Statistical Analysis and Relevant Structural Alerts
10.1186/1752-153x-4-s1-s2 · 2010 · External reference
Benchmark Data Set for In Silico Prediction of Ames Mutagenicity
10.1021/ci900161g · 2009 · External reference
Mechanisms of Chemical Carcinogenicity and Mutagenicity: A Review with Implications for Predictive Toxicology
10.1021/cr100222q · 2011 · External reference
In Vitro Cell Transformation Assays for an Integrated, Alternative Assessment of Carcinogenicity: A Data-based Analysis
10.1093/mutage/ges059 · 2013 · External reference
Structure Alerts of Genotoxic Impurities
2014 · External reference
Improvement of Quantitative Structure–Activity Relationship (QSAR) Tools for Predicting Ames Mutagenicity: Outcomes of the Ames/QSAR International Challenge Project
10.1093/mutage/gey031 · 2019 · External reference
Nanoparticles and Bone Microenvironment: A Comprehensive Review for Malignant Bone Tumor Diagnosis and Treatment
10.1186/s12943-024-02161-1 · 2024 · External reference
Targeting Tumor and Bone Microenvironment: Novel Therapeutic Opportunities for Castration-resistant Prostate Cancer Patients with Bone Metastasis
2024 · External reference
Evaluation of QSAR Models for Predicting Mutagenicity: Outcome of the Second Ames/QSAR International Challenge Project
10.1080/1062936x.2023.2284902 · 2023 · External reference
AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction
10.1021/acs.chemrestox.6c00082 · 2026 · External reference
